Thomas Richard Kassberg - Net Worth and Insider Trading
Thomas Richard Kassberg Net Worth
The estimated net worth of Thomas Richard Kassberg is at least $10 Million dollars as of 2024-05-11. Thomas Richard Kassberg is the CBO & EVP of Ultragenyx Pharmaceutical Inc and owns about 252,823 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $10 Million. Details can be seen in Thomas Richard Kassberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Richard Kassberg has not made any transactions after 2024-03-11 and currently still holds the listed stock(s).
Transaction Summary of Thomas Richard Kassberg
Thomas Richard Kassberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Richard Kassberg owns 1 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) .
Click here to see the complete history of Thomas Richard Kassberg’s form 4 insider trades.
Insider Ownership Summary of Thomas Richard Kassberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2024-03-11 | CBO & Senior Vice President |
Thomas Richard Kassberg Latest Holdings Summary
Thomas Richard Kassberg currently owns a total of 1 stock. Thomas Richard Kassberg owns 252,823 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 11, 2024, with a value of $10 Million.
Latest Holdings of Thomas Richard Kassberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2024-03-11 | 252,823 | 40.90 | 10,340,461 |
Holding Weightings of Thomas Richard Kassberg
Thomas Richard Kassberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Richard Kassberg has made a total of 9 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 11,509 shares on March 11, 2024, which brought Thomas Richard Kassberg around $574,644.
Insider Trading History of Thomas Richard Kassberg
- 1
Thomas Richard Kassberg Trading Performance
Thomas Richard Kassberg Ownership Network
Thomas Richard Kassberg Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Thomas Richard Kassberg is the CBO & Senior Vice President of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , EVP and General Counsel Karah Herdman Parschauer , and EVP & Chief Commercial Officer Erik Harris .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Thomas Richard Kassberg made 4 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 54,366. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 14,737 shares made by Erik Harris .
In summary, during the past 3 months, insiders sold 39,487 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 39,487 shares. During the past 18 months, 243,647 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,647 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Thomas Richard Kassberg Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Richard Kassberg. You might contact Thomas Richard Kassberg via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
